Background
High-throughput approaches to genomics, proteomics, and metabolomics have identified diverse candidate biomarkers of health and disease. Validated biomarkers coupled with new technologies for miniaturization and highly parallel detection could enable radically new ways to diagnose health and disease states in an individual, even in remote or impoverished settings.